Phoenix tissue bank Pinnacle Transplant Technologies is building up a repository of human tissues for allograft transplantation. It just raised $2.45 million in equity from 14 investors, according to a regulatory filing, and is on the expansion track.
The regenerative medicine company harvests tissue from cadavers, and then processes it so that it’s appropriate for a wide range of surgical transplants. Pinnacle is expanding its employee base, according to a recent Phoenix Business Journal article, to work in quality control and cadaveric tissue processing.
The company doesn’t say much on its proprietary tissue processing method, but says it’s able to rapidly demineralize bone with minimal manipulation.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Interestingly, the global market for tissue transplant is morphing significantly – 3D tissue development and full-organ growth are on the horizon. The global organ and tissue transplantation market was valued at $56.9 billion by the end of 2014. By 2020, it’s expected to reach $90.6 billion, according to a Companies and Markets report.
